Merck expands drug plant

Merck expands drug plant

JAKARTA: Publicly listed drug company PT Merck Indonesia Tbk,
a subsidiary of German firm Merck KGaA, has expanded its
production facilities in Pasar Rebo, Jakarta, to strengthen its
position in the Indonesian market.

The expansion project, which started in 2001 and was recently
completed, absorbed a total investment of Rp 40 billion (US$4.7
million), the company said in a statement on Tuesday.

"This is a clear evidence of Merck's determination to continue
its presence in Indonesia," president director Rudolf G. Stock
said.

Globally and in Indonesia, Merck is well known for its
diabetes and cardiovascular drugs. Its popular drugs include
Concor and Glocophage which are used to treat diabetes and
cardiovascular complaints respectively.

Aside from the above drugs, the firm also produces popular
health care products, such as Neurobion, Sangobion and Evion. --
JP